Showing results (401-410 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|June 9, 2017
Current options to manage Waldenström's macroglobulinemiaGiulia Benevolo, Maura Nicolosi, Elisa Santambrogio, et al.Expert Review of Hematology|June 21, 2017
Therapeutic monitoring of unfractionated heparin - trials and tribulationsIsrafil Baluwala, Emmanuel J Favaloro, Leonardo PasalicExpert Review of Hematology|June 24, 2017
Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategiesDian Winkelhorst, Dick Oepkes, Enrico LoprioreExpert Review of Hematology|February 10, 2022
Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassemia, and fetal hemoglobin in HbSSGraham R SerjeantExpert Review of Hematology|July 28, 2022
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutationsMingmin He, Yongqin Jia, Yan Wang, et al.Expert Review of Hematology|September 21, 2021
A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weeklyXavier Leleu, Ajai Chari, Shambavi Richard, et al.Expert Review of Hematology|May 17, 2018
Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparisonSam Keeping, Elise Wu, Keith Chan, et al.Expert Review of Hematology|November 29, 2023
Diagnosis of erythroid dysplasia by flow cytometry: a reviewMarc SorigueExpert Review of Hematology|September 6, 2023
Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimenAkihiro Ohmoto, Shigeo FujiExpert Review of Hematology|August 16, 2023
Role of daratumumab in the frontline management of multiple myeloma: a narrative reviewSanjeev Yadav, Sadashivudu Gundeti, Abhay Bhave, et al.Pageof 157